Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Akorn, Inc. (AKRX)

« Back to company index

AKRX Chatter Timeline

Stock Ticker for AKRX

Most Active Tweeters for AKRX

UserTweets
@ctfn_news 11
@1MinuteStock 11
@Biotech_DD 6
@injaelee 6
@leliangirard 5

Recent Tweets for AKRX

MarketChmln @MarketChmln
$AKRX option volume was 3X normal on Friday with 17,739 contracts. Call volume was 44% and put volume was 56%. https://t.co/gcguclSocy
July 15th 2018, 9:07am
MareaInformativ @MareaInformativ
Brokerages Anticipate Akorn, Inc. $AKRX to Announce $0.11 Earnings Per Share https://t.co/5FsYJUPOwt
July 15th 2018, 7:07am
EnterpriseLeade @EnterpriseLeade
Analysts Anticipate Akorn, Inc. $AKRX Will Post Earnings of $0.11 Per Share https://t.co/Hj7tOvj3m7
July 15th 2018, 6:07am
ledgerzette @ledgerzette
Akorn, Inc. $AKRX Expected to Post Quarterly Sales of $187.40 Million https://t.co/HYsTr0CRRl
July 15th 2018, 12:07am
TranscriptDaily @TranscriptDaily
Analyzing Akorn $AKRX & Aeglea Bio Therapeutics $AGLE https://t.co/J4Ntht0Wfx
July 14th 2018, 11:07pm
AmericanBanking @AmericanBanking
Analyzing Akorn $AKRX & Aeglea Bio Therapeutics $AGLE https://t.co/nZcw5ue9sJ #stocks
July 14th 2018, 11:07pm
MareaInformativ @MareaInformativ
Analyzing Akorn $AKRX & Aeglea Bio Therapeutics $AGLE https://t.co/XnKCbuFoiV
July 14th 2018, 11:07pm
iogitra @iogitra
Bagholding update: $AKRX - Broke even today after 4 months, don’t have the conviction to go through the trial resu… https://t.co/JqIVdI4Q4E
July 14th 2018, 12:07am
NewsQuantified @NewsQuantified
$AKRX drops 8% on fifth day of buyout fight trial, #Akorn https://t.co/uKJh7S4Eh2
July 13th 2018, 8:07pm
MC_OptionTrades @MC_OptionTrades
$AKRX Akorn Inc. Option Order Flow Sentiment is 53.6% Bullish. https://t.co/cQf34lWD7p
July 13th 2018, 8:07pm
1MinuteStock @1MinuteStock
Do you know that #Book Value for $AKRX is $6.47 https://t.co/71d5aLAlOO
July 13th 2018, 7:07pm
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $AKRX for you: 32.46% https://t.co/CMDm124tCj
July 13th 2018, 7:07pm
1MinuteStock @1MinuteStock
Explore #fundamental numbers and pros and cons for $AKRX https://t.co/mnEMzxubyL
July 13th 2018, 6:07pm
tq_equities @tq_equities
$AKRX TANKS, LOSES $1.30 (-6.77%) WITHIN A SINGLE DAY: https://t.co/1vJLSgFdnL Sentiment: Neutral #AKRX #Akorn
July 13th 2018, 4:07pm
MarketCurrents @MarketCurrents
Akorn down 8% as Fresenius trial winds up https://t.co/33rFxgxAiu $AKRX $FMS
July 13th 2018, 3:07pm
ctfn_news @ctfn_news
Further updates on the afternoon testimony: Day 5: Akorn v. Fresenius – CTFN https://t.co/X1ck8PKjoy $AKRX #delaware #mergers #corpgov
July 13th 2018, 3:07pm
mrcage80 @mrcage80
RT @trading_mz: *AKORN DROPS TO SESSION LOWS ON LAST DAY OF FRESENIUS TRIAL $AKRX
July 13th 2018, 3:07pm
trading_mz @trading_mz
*AKORN DROPS TO SESSION LOWS ON LAST DAY OF FRESENIUS TRIAL $AKRX
July 13th 2018, 3:07pm
injaelee @injaelee
$AKRX - 15min - This happens everyday. Market maker accumulation: Low volume sell-off hitting all the stops to boun… https://t.co/kbgv7mLVCr
July 13th 2018, 3:07pm
Star_Investor @Star_Investor
@megtirrell Why having you report on the trial between $AKRX and $FRE. Seems like it would be news that could set… https://t.co/szM3qz10CG
July 13th 2018, 12:07pm
ctfn_news @ctfn_news
Notes from the trial $AKRX https://t.co/X1ck8PKjoy #mergers #corpgov #pharma #stocks https://t.co/oayLmWgIOo
July 13th 2018, 11:07am
ethan_andino @ethan_andino
Planned to long $AKRX, didnt plan on if it cracked my risk to short it.Followed sheep; dip buy. Will have to do bet… https://t.co/Wd7WG6cuya
July 13th 2018, 10:07am
Arbtrader69 @Arbtrader69
RT @leliangirard: $AKRX up close to 8% on relatively heavy volume today (7m shares traded, highest since June 22nd).
July 13th 2018, 10:07am
charlesramsgate @charlesramsgate
$fre $akrx classic! pull out from the deal because 2q of weak sales, blame the Target for FDA approval issues...yet… https://t.co/mkkJFKQjcW
July 13th 2018, 7:07am
leliangirard @leliangirard
$AKRX day 4 trial: first 3 witnesses called by FRE have not presented meaningful support for deal break. Defense is… https://t.co/yoxyCBOLIx
July 13th 2018, 6:07am
VisualStockRSRC @VisualStockRSRC
$AKRX - Fresenius SE Had Testing Issues Like Akorn's, Executive Says -Bloomberg https://t.co/l9JqCoW0Tc
July 13th 2018, 5:07am
TranscriptDaily @TranscriptDaily
Akorn $AKRX Upgraded to Hold by Zacks Investment Research https://t.co/pfeaNDMI0R
July 13th 2018, 3:07am
1MinuteStock @1MinuteStock
We calculated 63-day Expected Return of $AKRX for you: 8.54% https://t.co/CMDm124tCj
July 13th 2018, 12:07am
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $AKRX for you: 21.18% https://t.co/CMDm124tCj
July 13th 2018, 12:07am
leliangirard @leliangirard
$AKRX up close to 8% on relatively heavy volume today (7m shares traded, highest since June 22nd).
July 12th 2018, 10:07pm
EquitySwing @EquitySwing
$AKRX BLOCKS ON [Jul 13, 2018] FOR AKRX #stocks #investing #trading #stockmarket https://t.co/gSRzMTJJ92
July 12th 2018, 9:07pm
ArbCapitol @ArbCapitol
Honestly, my personal and professional opinion have never aligned like this before. $AKRX is a piece of shit and no… https://t.co/H9Gs9U7cEG
July 12th 2018, 5:07pm
dimeB4steamroll @dimeB4steamroll
RE: $AKRX is there precedence for what happens if AKRX wins this lawsuit? Do they have to be then acquired? Is it at the same price terms?
July 12th 2018, 4:07pm
jamielissette @jamielissette
$AKRX trial hi's almost a double from May lows
July 12th 2018, 3:07pm
Biotech_DD @Biotech_DD
$AKRX Next stop $34 https://t.co/4qSIHN5Rrs
July 12th 2018, 3:07pm
Thekkw @Thekkw
$AKRX what a stud down 4% to open, up 4% at close
July 12th 2018, 3:07pm
ctfn_news @ctfn_news
Further updates .... $AKRX https://t.co/TAAhSeoR6I #corpgov #mergers #delaware #hedgefunds
July 12th 2018, 3:07pm
JuliaSkripkaSer @JuliaSkripkaSer
RT @Biotech_DD: $AKRX ripping 10% from intraday lows, now up 2.5% „FRESENIUS SAID TO HAVE HAD TESTING PROBLEMS SIMILAR TO AKORN'S“
July 12th 2018, 1:07pm
Biotech_DD @Biotech_DD
$AKRX ripping 10% from intraday lows, now up 2.5% „FRESENIUS SAID TO HAVE HAD TESTING PROBLEMS SIMILAR TO AKORN'S“
July 12th 2018, 1:07pm
injaelee @injaelee
$AKRX - Started the day with a -3%; now it's above +4%. ????? One of the Fresenius' witness must have said somethin… https://t.co/bBA5OiFlSQ
July 12th 2018, 1:07pm
ctfn_news @ctfn_news
Notes on the proceedings up to the lunch break: https://t.co/TAAhSeoR6I $AKRX #mergers #corpgov #delaware https://t.co/9rerCPylw7
July 12th 2018, 12:07pm
injaelee @injaelee
$AKRX - Two more days, including today, left for the trial. Prices are bouncing off the 02/2018 lows. ?? https://t.co/QQUP3XMkPd
July 12th 2018, 11:07am
leliangirard @leliangirard
$AKRX trial day 3: still no supporting evidence for MAC but still no Frenesius witness testimonies either. Today &… https://t.co/j2zVsyB1mD
July 12th 2018, 10:07am
dakotafinancial @dakotafinancial
Akorn $AKRX Stock Rating Upgraded by Zacks Investment Research https://t.co/0vhIIEepvl
July 12th 2018, 4:07am
dakotafinancial @dakotafinancial
$0.11 EPS Expected for Akorn, Inc. $AKRX This Quarter https://t.co/ItyCc1Fwpn
July 12th 2018, 4:07am
AmericanBanking @AmericanBanking
Brokerages Expect Akorn, Inc. $AKRX to Post $0.11 Earnings Per Share https://t.co/QncXWzF4XS #stocks
July 12th 2018, 4:07am
Star_Investor @Star_Investor
@ArbCapitol @WSJ I guess you are short. Odds are that the Judge will rule for $AKRX unless material facts can be pr… https://t.co/wMmMBa4bgL
July 11th 2018, 10:07pm
ArbCapitol @ArbCapitol
$AKRX I’d be surprised if this company is still around in a year if ANY of the charges are true. Who invests in a d… https://t.co/m8GHjN4UQn
July 11th 2018, 10:07pm
ArbCapitol @ArbCapitol
@WSJ $AKRX who is long this stock? Do you pray for a cut? Look at the comps of a poorly run generic drug co with sh… https://t.co/PifYNW5cwI
July 11th 2018, 9:07pm
hedge_funds @hedge_funds
RT @ctfn_news: More from the afternoon's testimony: https://t.co/HUOZLYdD7E $AKRX #pharma #delaware #hedgefunds https://t.co/38rUUh5PNF
July 11th 2018, 4:07pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.